Macular Degeneration X Linked Atrophic C3151784
An inherited eye condition causing progressive damage to the central part of vision. It primarily affects males and can lead to vision loss. Management includes low-vision aids and monitoring.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Central vision loss
Generalized symptoms
(ophthalmologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Macular atrophy
(ophthalmologic)Photophobia
(ophthalmologic)Night blindness
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anti-VEGF intravitreal injections
Vascular endothelial growth factor inhibitors administered via intraocular injection to reduce abnormal vessel growth and leakage. Regular ophthalmology follow-up essential for scheduling repeat treatments.
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Low vision rehabilitation
Comprehensive program including magnification devices, adaptive lighting, and training in daily living skills to maximize functional vision. May involve occupational therapy referral.
Additional treatment options
Antioxidant supplementation
AREDS2-formula supplements containing vitamins C, E, zinc, copper, lutein, and zeaxanthin to potentially slow disease progression. lifelong daily supplementation typically recommended.
medicationPhotodynamic therapy
Laser-activated drug therapy using verteporfin to selectively destroy abnormal choroidal vessels while sparing surrounding tissue. Less commonly used now with advent of anti-VEGF agents.
procedureSmoking cessation and UV protection
Complete smoking cessation and wearing UV-blocking sunglasses outdoors to minimize oxidative stress on retinal tissues. Environmental modifications to reduce risk factors.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Macular Degeneration X Linked Atrophic C3151784?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Macular Degeneration X Linked Atrophic C3151784. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy